Rocket Pharmaceuticals, Inc. (RCKTW) — DEF 14A Filings
All DEF 14A filings from Rocket Pharmaceuticals, Inc.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
Rocket Pharmaceuticals Files Definitive Proxy Statement
— Apr 30, 2025 Risk: low
Rocket Pharmaceuticals, Inc. filed its definitive proxy statement on April 30, 2025, for its annual meeting on June 18, 2025. The company, formerly known as Ino -
Rocket Pharmaceuticals, Inc. Announces 2024 Annual Meeting of Stockholders
— Apr 29, 2024 Risk: low
ROCKET PHARMACEUTICALS, INC. (RCKTW) filed a Proxy Statement (DEF 14A) with the SEC on April 29, 2024. The 2024 Annual Meeting of Stockholders for Rocket Pharma
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX